Title | Diabetes Technology and Therapeutics |
Standard Abbreviation | Diabetes Technol. Ther. |
Type of Publication | Journal |
Discipline | Endocrinology (Q1); Endocrinology, Diabetes and Metabolism (Q1); Medical Laboratory Technology (Q1); Medicine (miscellaneous) (Q1) |
Impact Score | 5.24 |
SCImago Journal Rank (SJR) | 2.374 |
h-index | 97 |
Overall Rank | 986 |
Publisher Name | Mary Ann Liebert Inc. |
Publication Country | United States |
International Standard Serial Number (ISSN) | 15209156, 15578593 |
Coverage and History | 1999-2022 |
Best Quartile | Q1 |
Total Citations Received (Last 3 Year) |
2273 |
Diabetes Technology and Therapeutics is a journal published by Mary Ann Liebert Inc.. This journal covers the area[s] related to Endocrinology, Endocrinology, Diabetes and Metabolism, Medical Laboratory Technology, Medicine (miscellaneous), etc.
The coverage history of this journal is as follows: 1999-2022.
The rank of this journal is 986. This journal's impact score, h-index, and SJR are 5.24, 97, and 2.374, respectively. The ISSN of this journal is/are as follows: 15209156, 15578593.
The best quartile of Diabetes Technology and Therapeutics is Q1.
This journal has received a total of 2273 citations during the last three years (Preceding 2022).
The latest impact score (IS) of the Diabetes Technology and Therapeutics is 5.24. It is computed in the year 2023 as per its definition and based on Scopus data.
5.24
It is decreased by a factor of around 0.19, and the percentage change is -3.5% compared to the preceding year 2021, indicating a falling trend.
The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact Score 2022 of Diabetes Technology and Therapeutics is 5.24. If a similar downward trend continues, IS may decrease in 2023 as well.
Year | Impact Score (IS) |
---|---|
2023/2024 | Coming Soon |
2022 | 5.24 |
2021 | 5.43 |
2020 | 4.51 |
2019 | 4.26 |
2018 | 3.16 |
2017 | 1.65 |
2016 | 1.60 |
2015 | 1.50 |
2014 | 1.94 |
The h-index of Diabetes Technology and Therapeutics is 97. By definition of the h-index, this journal has at least 97 published articles with more than 97 citations.
The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.
The International Standard Serial Number (ISSN) of Diabetes Technology and Therapeutics is/are as follows: 15209156, 15578593.
The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.
ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}
The Diabetes Technology and Therapeutics is ranked 986 among 27955 Journals, Conferences, and Book Series.
As per SJR, this journal is ranked 2.374.
SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
The publisher of Diabetes Technology and Therapeutics is Mary Ann Liebert Inc.. The publishing house of this journal is located in the United States. Its coverage history is as follows: 1999-2022.
Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).
The International Organization for Standardization 4 (ISO 4) abbreviation of Diabetes Technology and Therapeutics is Diabetes Technol. Ther.. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).
As ISO 4 is an international standard, the abbreviation ('Diabetes Technol. Ther.') can be used for citing, indexing, abstraction, and referencing purposes.
If your area of research or discipline is related to Endocrinology, Endocrinology, Diabetes and Metabolism, Medical Laboratory Technology, Medicine (miscellaneous), etc., please check the journal's official website to understand the complete publication process.
There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:
The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.
The latest impact score of Diabetes Technology and Therapeutics is 5.24. It is computed in the year 2023.
The latest h-index of Diabetes Technology and Therapeutics is 97. It is evaluated in the year 2023.
The latest SCImago Journal Rank (SJR) of Diabetes Technology and Therapeutics is 2.374. It is calculated in the year 2023.
The latest ranking of Diabetes Technology and Therapeutics is 986. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.
Diabetes Technology and Therapeutics is published by Mary Ann Liebert Inc.. The publication country of this journal is United States.
This standard abbreviation of Diabetes Technology and Therapeutics is Diabetes Technol. Ther..
Diabetes Technology and Therapeutics is a journal published by Mary Ann Liebert Inc..
The scope of Diabetes Technology and Therapeutics is as follows:
For detailed scope of Diabetes Technology and Therapeutics, check the official website of this journal.
The International Standard Serial Number (ISSN) of Diabetes Technology and Therapeutics is/are as follows: 15209156, 15578593.
The best quartile for Diabetes Technology and Therapeutics is Q1.
The coverage history of Diabetes Technology and Therapeutics is as follows 1999-2022.
Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.
Journal/Conference/Book Title | Type | Publisher | Ranking | SJR | h-index | Impact Score |
---|---|---|---|---|---|---|
Journal of Field Archaeology | Journal | Maney Publishing | 5639 | 43 | 2.38 | |
Proceedings of the Spring Technical Conference of the ASME Internal Combustion Engine Division | Conference And Proceedings | 17477 | 16 | 0.00 | ||
Qualitative Research | Journal | SAGE Publications Ltd | 2108 | 86 | 3.97 | |
Syntax | Journal | Wiley-Blackwell Publishing Ltd | 3422 | 29 | 0.93 | |
Studies in Continuing Education | Journal | Routledge | 6011 | 38 | 2.81 | |
Educational Measurement: Issues and Practice | Journal | Wiley-Blackwell Publishing Ltd | 4494 | 59 | 1.53 | |
Proceedings of the International Semiconductor Conference, CAS | Conference And Proceedings | Institute of Electrical and Electronics Engineers Inc. | 25734 | 16 | 0.00 | |
Asian Textile Journal | Trade Journal | G P S Kwatra | 27455 | 10 | 0.01 | |
Epigenetics | Journal | Landes Bioscience | 2362 | 105 | 4.11 | |
SPE International Formation Damage Control Symposium Proceedings | Conference And Proceedings | 21934 | 16 | 0.00 |
Year | Impact Score (IS) |
---|---|
2023/2024 | Updated Soon |
2022 | 5.24 |
2021 | 5.43 |
2020 | 4.51 |
2019 | 4.26 |
2018 | 3.16 |
2017 | 1.65 |
2016 | 1.60 |
2015 | 1.50 |
2014 | 1.94 |